Health Catalyst Narrows FY2024 Sales Guidance From $304.00M-312.00M to $305.00M-311.00M
Health Catalyst Narrows FY2024 Sales Guidance From $304.00M-312.00M to $305.00M-311.00M
health catalyst將2024財年銷售指導範圍從30400萬-31200萬縮小到30500萬311.00百萬
Health Catalyst (NASDAQ:HCAT) narrows FY2024 sales outlook from $304.00 million-312.00 million to $305.00 million-311.00 million.
health catalyst(納斯達克:HCAT)將2024財年銷售前景範圍從30400萬至-31200萬縮小至30500萬至-31100萬
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。